212 related articles for article (PubMed ID: 29251944)
1. Improved Protease-Targeting and Biopharmaceutical Properties of Novel Prodrugs of Ganciclovir.
Sun K; Xu H; Hilfinger JL; Lee KD; Provoda CJ; Sabit H; Amidon GL
Mol Pharm; 2018 Feb; 15(2):410-419. PubMed ID: 29251944
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus protease targeted prodrug development.
Sabit H; Dahan A; Sun J; Provoda CJ; Lee KD; Hilfinger JH; Amidon GL
Mol Pharm; 2013 Apr; 10(4):1417-24. PubMed ID: 23485093
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, physicochemical properties and antiviral activities of ester prodrugs of ganciclovir.
Patel K; Trivedi S; Luo S; Zhu X; Pal D; Kern ER; Mitra AK
Int J Pharm; 2005 Nov; 305(1-2):75-89. PubMed ID: 16242278
[TBL] [Abstract][Full Text] [Related]
4. Uptake and bioconversion of stereoisomeric dipeptide prodrugs of ganciclovir by nanoparticulate carriers in corneal epithelial cells.
Yang X; Sheng Y; Ray A; Shah SJ; Trinh HM; Pal D; Mitra AK
Drug Deliv; 2016 Sep; 23(7):2532-2540. PubMed ID: 25775276
[TBL] [Abstract][Full Text] [Related]
5. Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
Gupta D; Varghese Gupta S; Dahan A; Tsume Y; Hilfinger J; Lee KD; Amidon GL
Mol Pharm; 2013 Feb; 10(2):512-22. PubMed ID: 23244438
[TBL] [Abstract][Full Text] [Related]
6. Amino acid ester prodrugs of 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole enhance metabolic stability in vitro and in vivo.
Lorenzi PL; Landowski CP; Song X; Borysko KZ; Breitenbach JM; Kim JS; Hilfinger JM; Townsend LB; Drach JC; Amidon GL
J Pharmacol Exp Ther; 2005 Aug; 314(2):883-90. PubMed ID: 15901797
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, enzymatic hydrolysis and physico-chemical properties of N-substituted 4-(aminomethyl)benzoate diester prodrugs of ganciclovir.
Jensen E; Bundgaard H
Acta Pharm Nord; 1991; 3(4):243-7. PubMed ID: 1781915
[TBL] [Abstract][Full Text] [Related]
8. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y; Hilfinger JM; Amidon GL
Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability.
Borthwick AD; Davies DE; Ertl PF; Exall AM; Haley TM; Hart GJ; Jackson DL; Parry NR; Patikis A; Trivedi N; Weingarten GG; Woolven JM
J Med Chem; 2003 Oct; 46(21):4428-49. PubMed ID: 14521407
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological activation of an ethylene glycol-linked amino acid conjugate of cyclic cidofovir.
Eriksson U; Hilfinger JM; Kim JS; Mitchell S; Kijek P; Borysko KZ; Breitenbach JM; Drach JC; Kashemirov BA; McKenna CE
Bioorg Med Chem Lett; 2007 Feb; 17(3):583-6. PubMed ID: 17161946
[TBL] [Abstract][Full Text] [Related]
12. Serine peptide phosphoester prodrugs of cyclic cidofovir: synthesis, transport, and antiviral activity.
Eriksson U; Peterson LW; Kashemirov BA; Hilfinger JM; Drach JC; Borysko KZ; Breitenbach JM; Kim JS; Mitchell S; Kijek P; McKenna CE
Mol Pharm; 2008; 5(4):598-609. PubMed ID: 18481868
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Antiviral Spectrum of 3-Fluoro-2-(phosphonomethoxy)propyl Acyclic Nucleoside Phosphonates: Diamyl Aspartate Amidate Prodrugs.
Luo M; Groaz E; Andrei G; Snoeck R; Kalkeri R; Ptak RG; Hartman T; Buckheit RW; Schols D; De Jonghe S; Herdewijn P
J Med Chem; 2017 Jul; 60(14):6220-6238. PubMed ID: 28682067
[TBL] [Abstract][Full Text] [Related]
14. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
15. Corneal permeation of ganciclovir: mechanism of ganciclovir permeation enhancement by acyl ester prodrug design.
Tirucherai GS; Dias C; Mitra AK
J Ocul Pharmacol Ther; 2002 Dec; 18(6):535-48. PubMed ID: 12537680
[TBL] [Abstract][Full Text] [Related]
16. L-valine ester of cyclopropavir: a new antiviral prodrug.
Wu Z; Drach JC; Prichard MN; Yanachkova M; Yanachkov I; Bowlin TL; Zemlicka J
Antivir Chem Chemother; 2009 Sep; 20(1):37-46. PubMed ID: 19794230
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 2-amino-9-(1, 3-dihydroxy-2-propoxymethyl)- 6-fluoropurine mono- and diesters as potential prodrugs of ganciclovir.
Kim DK; Chang K; Im GJ; Kim HT; Lee N; Kim KH
J Med Chem; 1999 Jan; 42(2):324-8. PubMed ID: 9925738
[TBL] [Abstract][Full Text] [Related]
18. Design of translactam HCMV protease inhibitors as potent antivirals.
Borthwick AD
Med Res Rev; 2005 Jul; 25(4):427-52. PubMed ID: 15789440
[TBL] [Abstract][Full Text] [Related]
19. Dipeptide monoester ganciclovir prodrugs for transscleral drug delivery: targeting the oligopeptide transporter on rabbit retina.
Kansara V; Hao Y; Mitra AK
J Ocul Pharmacol Ther; 2007 Aug; 23(4):321-34. PubMed ID: 17803430
[TBL] [Abstract][Full Text] [Related]
20. A novel nucleoside prodrug-activating enzyme: substrate specificity of biphenyl hydrolase-like protein.
Kim I; Song X; Vig BS; Mittal S; Shin HC; Lorenzi PJ; Amidon GL
Mol Pharm; 2004; 1(2):117-27. PubMed ID: 15832508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
